作者
Kirsty Taylor, Helen Loo Yau, Ankur Chakravarthy, Ben Wang, Shu Yi Shen, Ilias Ettayebi, Charles A Ishak, Philippe L Bedard, Albiruni Abdul Razak, Aaron R Hansen, Anna Spreafico, Dave Cescon, Marcus O Butler, Amit M Oza, Stephanie Lheureux, Neda Stjepanovic, Brendan Van As, Sarah Boross-Harmer, Lisa Wang, Trevor J Pugh, Pamela S Ohashi, Lillian L Siu, Daniel D De Carvalho
发表日期
2020
期刊
Journal for immunotherapy of cancer
卷号
8
期号
2
出版商
BMJ Publishing Group
简介
Purpose
To evaluate whether administration of the oral DNA hypomethylating agent CC-486 enhances the poor response rate of immunologically ‘cold’solid tumors to immune checkpoint inhibitor durvalumab.
学术搜索中的文章
K Taylor, HL Yau, A Chakravarthy, B Wang, SY Shen… - Journal for immunotherapy of cancer, 2020